BioSig Technologies, Inc. (NASDAQ:BSGM) has entered a definitive share exchange agreement with Streamex Exchange Corp, which initiates a bold shift from medical technology to blockchain-powered real-world asset (RWA) tokenization. As per the agreement, Streamex will become a wholly owned subsidiary with its shareholders expected to hold 75% of BioSig’s fully diluted common stock, pending shareholder approval.BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition

A cardiac surgeon demonstrating a simulated ablation procedure with a signal processing platform.

In the combined entity, Streamex’s co-founder, Henry McPhie, will step in as CEO, and Morgan Lekstrom will take on the role of Chairman. Current BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Anthony Amato will transition to a board role, signaling the company’s retreat from its original medical tech identity. Complying with regulations, the company has initially issued 19.9% of shares to Streamex investors and awaits full approval.

The transaction has attracted strategic advisors with high profiles, including Frank Giustra, the founder of Wheaton Precious Metals and GoldCorp, indicating the noteworthiness of the company’s entry into the $142.85 trillion global commodity sector. Leveraging its vertically integrated infrastructure, Streamex can gain a competitive edge with tokenization poised to address inefficiencies in commodity trading and settlement.

On the other hand, BioSig Technologies, Inc. (NASDAQ:BSGM)’s radical shift introduces considerable uncertainty. Existing shareholder equity is diluted, and the company is also exposed to the operational risks inherent in shifting industries. Additionally, the technical specifications regarding Streamex’s blockchain framework have also not been disclosed yet.

Notably, while the institutional transaction in BioSig Technologies, Inc. (NASDAQ:BSGM) has increased by 218.41%, the insider transaction remains neutral at 0.00% over the last six months.

BSGM could be a potential investment opportunity. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSGM and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Unstoppable Dividend Stocks to Buy Nowand 11 Oversold Global Stocks to Buy According to Hedge Funds

Disclosure: None.

View Comments